RemSleep receives OTCQB status
By HME News Staff
Updated 10:21 AM CDT, Wed July 13, 2022
TAMPA, Fla. – RemSleep Holdings has received approval to be uplisted to OTCQB status with otcmarkets.com. “This is a great milestone for RemSleep and our shareholders,” said Tom Wood, CEO. “We could not be more excited for where we are currently positioned and the trajectory of where we are going. Uplisting to OTCQB status provides next level accountability from us as a company with higher reporting standards and more comprehensive compliance requirements.” RemSleep filed its application in June. RemSleep is also awaiting approval from the U.S. Food and Drug Administration for its patented DeltaWave nasal mask CPAP interface.
Comments